Yasin Keshvargar

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Evolent Health, Inc. of $125 million aggregate principal amount of its 2.00% senior convertible notes…

Davis Polk advised the representative of the several underwriters in connection with an SEC-registered secondary offering of 1,568,000 shares of Veritiv Corporation’s common stock by UWW…

Davis Polk advised Banco de Bogotá S.A. in connection with a reopening of $500 million aggregate principal amount of its 6.250% subordinated notes due 2026, pursuant to Rule 144A and…

Davis Polk advised Advanced Accelerator Applications S.A. on its approximately $150 million SEC-registered follow-on offering of American Depositary Shares representing its ordinary shares…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering of $400 million aggregate principal amount of Callon Petroleum Company’s 6.125% senior…

Davis Polk advised the representatives of the several underwriters, in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 29,900,000 shares of common stock of Callon Petroleum Company (“Callon”). The…

Davis Polk advised the initial purchaser in connection with a Rule 144A/Regulation S offering of $535 million aggregate principal amount of 6.125% senior notes due 2023 by XPO Logistics,…

Davis Polk advised the representatives of the initial purchasers on Rule 144A/Regulation S offerings by Mylan N.V. (“Mylan”) of $1.0 billion aggregate principal amount of its 2.500% senior…

Davis Polk advised the joint book-running managers in connection with an offering by Eastman Chemical Company of €550 million aggregate principal amount of its 1.50% notes due 2023. …